Cure My Disease

Don't miss your cure!

 Log in / Sign up

Stomach lining may hold clues to pancreatitis outcomes

NCT ID NCT07714850

Knowledge-focused Sponsor: Jan Kochanowski University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This study looks at whether early endoscopic findings in the stomach and duodenum can help predict how severe acute pancreatitis will become. Researchers will perform an upper GI endoscopy within 24-48 hours of hospital admission in 200 adult patients with acute pancreatitis. They will track whether certain mucosal abnormalities are linked to complications, organ failure, or longer hospital stays. The goal is to improve early risk assessment for this painful and potentially serious condition.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors predict which patients with acute pancreatitis will develop severe complications, enabling earlier and more targeted treatment.
What could go wrong
This is an observational study, not a treatment trial, so it cannot directly improve outcomes. The findings may not be generalizable beyond the specific hospital setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Sep 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients hospitalized at the study center with acute pancreatitis diagnosed according to the revised Atlanta criteria. Eligible participants will be enrolled during the early phase of hospitalization after providing written informed consent. The study population will include patients with different etiologies of acute pancreatitis, including biliary, alcoholic, hypertriglyceridemic, post-ERCP, idiopathic, and other causes. Patients must be clinically stable enough to undergo diagnostic upper gastrointestinal endoscopy within 24-48 hours from hospital admission. Patients in whom endoscopy is unsafe or contraindicated will not be enrolled.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older. * Diagnosis of acute pancreatitis according to the revised Atlanta criteria, defined by the presence of at least two of the following three features: typical abdominal pain consistent with acute pancreatitis; serum amylase and/or lipase activity at least three times the upper limit of normal; imaging findings consistent with acute pancreatitis. * Hospital admission due to acute pancreatitis to the study center. * Admission during the early phase of acute pancreatitis, allowing planned upper gastrointestinal endoscopy within 24-48 hours from hospital admission. * Ability to undergo diagnostic upper gastrointestinal endoscopy according to the investigator's and treating physician's assessment. * Ability to provide written informed consent before enrollment and before any study-specific procedure. Exclusion Criteria: * Age below 18 years. * Lack of written informed consent. * Inability to provide informed consent before enrollment. * Clinical condition precluding safe diagnostic upper gastrointestinal endoscopy, including hemodynamic instability, severe respiratory failure, or other unstable life-threatening condition. * Need for emergency therapeutic upper gastrointestinal endoscopy before planned study endoscopy, for example due to active upper gastrointestinal bleeding. * Known or suspected gastrointestinal perforation. * Previous gastric or duodenal surgery significantly altering upper gastrointestinal anatomy and preventing reliable assessment of gastric or duodenal mucosa. * Known advanced upper gastrointestinal malignancy affecting the stomach or duodenum. * Pregnancy. * Contraindication to upper gastrointestinal endoscopy or sedation according to the treating physician's or investigator's assessment. * Any condition that, in the investigator's opinion, would make participation unsafe or would prevent completion of study procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute pancreatitis (AP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute pancreatitis pancreatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute pancreatitis (AP)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.